Laporan Laba Rugi PHAR - TTM - Pharming Group N.V. - Depositary Receipt (Common Stock)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pharming Group N.V. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	180	212	172	200	173	199	202	202	204	206	202	206	219	245	258	278	286	297	321	340
Change (%)		17.63	-18.73	16.19	-13.70	15.01	1.54	0.23	0.68	0.91	-1.98	2.36	6.02	12.16	5.32	7.43	2.95	4.01	7.91	5.96
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	20	24	19	21	30	21	21	21	4	18	17	18	24	25	30	32	30	35	35	36
Change (%)		19.06	-18.36	11.03	39.57	-29.01	0.16	-2.90	-81.40	359.14	-4.57	10.11	32.04	3.46	17.10	7.64	-4.64	16.81	-0.18	2.80
% of Revenue	10.96	11.09	11.14	10.65	17.22	10.63	10.49	10.16	1.88	8.54	8.32	8.95	11.14	10.28	11.43	11.45	10.61	11.91	11.02	10.69

Gross Operating Profit	161	189	153	179	143	178	181	182	200	188	185	188	194	220	229	246	255	262	285	304
Change (%)		17.45	-18.77	16.84	-20.05	24.17	1.70	0.60	9.96	-5.94	-1.74	1.65	3.47	13.25	3.97	7.40	3.93	2.49	9.00	6.36
% of Revenue	89.04	88.91	88.86	89.35	82.78	89.37	89.51	89.84	98.12	91.46	91.68	91.05	88.86	89.72	88.57	88.55	89.39	88.09	88.98	89.31

SG&A	64	76	68	83	76	91	94	100	110	127	140	157	160	175	184	187	195	184	190	199
Change (%)		18.92	-10.48	22.18	-8.36	19.91	3.22	6.60	9.74	16.02	9.54	12.14	2.31	9.43	4.71	1.99	4.26	-5.49	3.26	4.57
% of Revenue	35.29	35.67	39.29	41.32	43.88	45.74	46.50	49.46	53.91	61.98	69.27	75.89	73.23	71.44	71.03	67.44	68.29	62.05	59.38	58.60

R&D	28	39	35	44	41	65	70	70	69	53	53	60	68	69	72	72	72	83	84	88
Change (%)		38.96	-10.31	26.68	-5.71	58.43	6.37	1.33	-1.46	-24.35	1.44	12.16	14.07	0.71	4.23	0.95	-0.04	15.14	0.63	5.02
% of Revenue	15.37	18.15	20.03	21.84	23.87	32.87	34.44	34.82	34.08	25.55	26.44	28.97	31.17	27.99	27.70	26.03	25.27	27.98	26.09	25.86

OpEx	110	136	120	145	145	175	181	188	167	195	208	233	243	267	283	289	295	301	307	320
Change (%)		23.25	-11.75	21.11	-0.52	21.00	3.72	3.43	-11.15	17.13	6.36	12.35	4.25	9.80	5.88	2.31	2.06	1.87	2.14	4.22
% of Revenue	61.14	64.06	69.56	72.50	83.58	87.93	89.83	92.69	81.80	94.96	103.04	113.10	111.20	108.87	109.44	104.23	103.33	101.21	95.80	94.22

Operating Income	70	76	52	55	28	24	21	15	37	10	-6	-27	-24	-22	-24	-12	-10	-4	13	20
Change (%)		8.78	-31.16	4.97	-48.47	-15.47	-14.41	-28.02	150.76	-72.04	-159.04	341.35	-9.31	-11.22	12.18	-51.89	-18.91	-62.24	-474.90	45.79
% of Revenue	38.86	35.94	30.44	27.50	16.42	12.07	10.17	7.31	18.20	5.04	-3.04	-13.10	-11.20	-8.87	-9.44	-4.23	-3.33	-1.21	4.20	5.78

Interest Expense	-11	-6				-6	-6	-6	-6	-5	-7	-6	-6	-6	-5	-7	-9	-9	-12	-10
Change (%)		-47.88					-3.60	-3.37	-1.25	-4.37	26.43	-17.36	7.20	-0.62	-20.77	38.10	35.34	-1.06	40.54	-16.04
% of Revenue	-6.32	-2.80				-3.06	-2.91	-2.80	-2.75	-2.61	-3.36	-2.71	-2.74	-2.43	-1.83	-2.35	-3.09	-2.94	-3.83	-3.03

Net Income	38	38	32	31	19	16	11	21	30	14	-2	-16	-22	-11	-11	-13	-18	-12	-14	-8
Change (%)		0.03	-16.13	-3.39	-37.66	-16.10	-31.65	90.66	45.67	-54.97	-114.59	722.96	34.33	-52.17	2.28	23.52	33.76	-33.56	19.18	-41.89
% of Revenue	20.92	17.79	18.36	15.27	11.03	8.04	5.41	10.30	14.90	6.65	-0.99	-7.96	-10.08	-4.30	-4.18	-4.80	-6.24	-3.98	-4.40	-2.41

Source: Capital IQ

Pharming Group N.V. - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings